Keon Mahmoudi

Keon Mahmoudi

Auto-generated profile, based on publicly available information

Keon Mahmoudi

Department of Radiology and Biomedical Imaging (Y.Y., M.A., M.T., C.P.H., K.M., K.N.), University of California, San Francisco

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2018 in International Journal of Hyperthermia
Verified
Journal Article
Closed access
KMKeon Mahmoudi
Keon Mahmoudi
ABAlexandros Bouras
Alexandros Bouras
DBDominique Bozec
Dominique Bozec
RIRobert Ivkov
Robert Ivkov
CHConstantinos G. Hadjipanayis
Constantinos G. Hadjipanayis
Hyperthermia therapy (HT) is the exposure of a region of the body to elevated temperatures to achieve a therapeutic effect. HT anticancer properties and its potential as a cancer treatment have been studied for decades. Techniques used to achieve a localised hyperthermic effect include radiofrequency, ultrasound, microwave, laser and magnetic nanoparticles (MNPs). The use of MNPs for therapeutic hyperthermia generation is known as magnetic hyperthermia therapy (MHT) and was first attempted as a cancer therapy in 1957. However, despite more recent advancements, MHT has still not become part of the standard of care for cancer treatment. Certain challenges, such as accurate thermometry within the tumour mass and precise tumour heating, preclude its widespread application as a treatment modality for cancer. MHT is especially attractive for the treatment of glioblastoma (GBM), the most common and aggressive primary brain cancer in adults, which has no cure. In this review, the application of MHT as a therapeutic modality for GBM will be discussed. Its therapeutic efficacy, technical details, and major experimental and clinical findings will be reviewed and analysed. Finally, current limitations, areas of improvement, and future directions will be discussed in depth.

18 January 2019 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
KMK. Mahmoudi
K. Mahmoudi
KGK. L. Garvey
K. L. Garvey
ABA. Bouras
A. Bouras
GCG. Cramer
G. Cramer
HSH. Stepp
H. Stepp
CHConstantinos G. Hadjipanayis
Constantinos G. Hadjipanayis

25 June 2020 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
PBP. Belani
P. Belani
JSJavin Schefflein
Javin Schefflein
SKShingo Kihira
Shingo Kihira
BRB. Rigney
B. Rigney
BDB.N. Delman
B.N. Delman
ADA.H. Doshi
A.H. Doshi
BACKGROUND AND PURPOSE: Coronavirus disease 2019 (COVID-19) is an active worldwide pandemic with diverse complications. Stroke as a presentation has not been strongly associated with COVID-19. The authors aimed to retrospectively review a link between COVID-19 and acute stroke. MATERIALS AND METHODS: We conducted a retrospective case-control study of 41 cases and 82 control subjects matched by age, sex, and risk factors. Cases were patients who underwent stroke alert imaging with confirmed acute stroke on imaging between March 16 and April 5, 2020, at 6 hospitals across New York City. Control subjects were those who underwent stroke alertimaging during the same timeframe without imaging evidence of acute infarction. Data pertaining to diagnosis of COVID-19 infection, patient demographics, and risk factors were collected. A univariate analysis was performed to assess the covariate effect of risk factors and COVID-19 status on stroke imaging with positive findings. RESULTS: The mean age for cases and controls was 65.5 ± 15.3 years and 68.8 ± 13.2 years, respectively. Of patients with acute ischemic stroke, 46.3% had COVID-19 infection compared with 18.3% of controls (P = .001). After adjusting for age, sex, and risk factors, COVID-19 infection had a significant independent association with acute ischemic stroke compared with control subjects (OR, 3.9; 95% CI, 1.7–8.9; P = .001). CONCLUSIONS: We demonstrated that COVID-19 infection is significantly associated with imaging confirmation of acute ischemic stroke, and patients with COVID-19 should undergo more aggressive monitoring for stroke.

1 January 2021 in American Journal of Roentgenology
Verified
Journal Article
Closed access
SKShingo Kihira
Shingo Kihira
JSJavin Schefflein
Javin Schefflein
KMKeon Mahmoudi
Keon Mahmoudi
BRBrian Rigney
Brian Rigney
BDBradley N. Delman
Bradley N. Delman
PBPuneet Belani
Puneet Belani
BACKGROUND. An increase in frequency of acute ischemic strokes has been observed among patients presenting with acute neurologic symptoms during the coronavirus disease (COVID-19) pandemic. OBJECTI...

3 December 2014 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
KMKeon Mahmoudi
Keon Mahmoudi
CHCostas G. Hadjipanayis
Costas G. Hadjipanayis
The application of magnetic nanoparticles for the treatment of brain tumors

1 November 2015 in Molecular Aspects of Medicine
Verified
Journal Article
Closed access
KMKeon Mahmoudi
Keon Mahmoudi
AEAlan Ezrin
Alan Ezrin
CHCostas Hadjipanayis
Costas Hadjipanayis